Open Access
Translator Disclaimer
1 October 2003 Comparative Aspects of Intracellular Proteolytic Processing of Peptide Hormone Precursors: Studies of Proopiomelanocortin Processing
Shigeyasu Tanaka
Author Affiliations +
Abstract

In this review, the mechanisms underlying the intracellular processing of peptide hormone precursors, with a focus on proopiomelanocortin (POMC), were discussed on the basis of recent information. POMC as well as other prohormones is processed to active peptides through proteolytic cleavage by prohormone convertases PC1 and/or PC2. However, the cleavage-specificity of PC1 and PC2 in mammals is somewhat different from that in amphibians. From the comparative endocrinological point of view, expression and tissue distribution of PC1 and PC2 were discussed here. In mammals, proteolytic processing of POMC occurs coordinately with the maturation of secretory granules. Studies using immunoelectron microscopy with DAMP (3-[2,4-dinitroanilino]-3′-amino-N-methyldipropylamine) as a pH probe revealed that the acidic pH in the secretory granules, generated by vacular type-H -ATPase, provides a favorable environment for activating PC1 in AtT-20 cells, a mouse corticotrope tumor cell line. Recent data indicate that the 7B2 protein serves as a chaperone in the regulation of PC2 activation and to control the timing for activating the convertase. Together, secretory granules in endocrine and neuroendocrine cells provide proper sites for biosynthesizing hormones in addition to serving as storage sites and vehicles for the transport of peptide hormones.

INTRODUCTION

In endocrine and neuroendocrine cells, most peptide hormones and neuropeptides are produced from larger, inactive precursors through limited endoproteolysis at pairs of basic amino acid residues during their transport through the exocytic pathway. This process is known as intracellular processing. In general, because peptide hormones acquire physiological activities for the first time after the proteolytic cleavage of their prohormones, the intracellular processing by processing enzymes (prohormone convertases) is an important step not only as a part of the biosynthetic process, but also as a regulatory step in diverse physiological processes in a variety of organisms. Among the prohormones, some contain a segment in which the peptide hormone sequence is located in the N-terminal region [e.g., pro-atrial natriuretic peptide (ANP), pro-gonadotropin-releasing hormone (GnRH), pro-pancreatic polypeptide, and pro-vasopressin] or in the C-terminal region [e.g., pro-corticotropin-releasing hormone (CRH), pro-melanin-concentrating hormone, pro-parathyroid hormone, and pro-somatostatin]. Some prohormones contain many different potential hormones joined together [e.g., pro-opiomelanocortin (POMC), pro-enkephalin, and pro-glucagon] or many similar peptides in the form of repeating units (e.g., pro-thyrotropin-releasing hormone). Others are processed to their active forms by liberating segments from both N- and C-terminal regions [e.g., pro-calcitonin, pro-calcitonin gene-related peptide (CGRP), and pro-glucagon)] or from a central portion in the proprotein (e.g., pro-insulin).

In this review, the molecular mechanisms underlying the intracellular processing of peptide hormone precursors (with POMC as a prototype) is discussed on the basis of information obtained recently.

Discovery of prohormone convertases

Prohormone convertase, which had been sought for a long time since the discovery of proinsulin, has been characterized by molecular techniques. This progress is largely attributable to the research on KEX2, the gene responsible for the cleavage at paired basic residues of pro-α-mating factor and pro-killer toxin in yeast (Steiner, 1991). Yeast Kex2 enzyme was shown to cleave mammalian prohormones in a number of mammalian cell lines (Thomas et al., 1988), but initially mammalian prohormone convertases could not be identified. Later, however, a homology search on the KEX2 gene revealed that furin, a human gene product previously thought to be a proto-oncogene, was shown high homology with Kex2 protease, and thus it was identified as a mammalian processing enzyme (Fuller et al., 1989). Based on this important breakthrough, mammalian prohormone convertases PC1 (also called PC3) and PC2 were cloned from mammalian endocrine cells by using a PCR strategy with primers based on the highly conserved nucleotide sequences encoding the active site of Kex2 (Seidah et al., 1990; Smeekens and Steiner, 1990). Other proprotein convertases were subsequently identified as PC4, PACE (paired basic amino acid residue-cleaving enzyme) 4, PC5 (also called PC6), and PC7 (Rouille et al., 1995; Seidah and Chretien, 1999; Zhou et al., 1999). Among these convertases, only PC1 and PC2 are considered to be involved in the cleavage of peptide hormones and neuropeptides.

Tissue-specific processing

In mammals, adrenocorticotropin (ACTH)-related peptides in corticotropes in the pars distalis and α-melanocyte-stimulating hormone (α-MSH)-related peptides in melanotropes in the pars intermedia of the pituitary are known to be produced posttranslationally by intracellular proteolytic cleavage of the large precursor molecule known as POMC. Nevertheless, the processing of POMC differs between these 2 lobes: in corticotropes ACTH, β-lipotropic hormone (β-LPH), and a 16-K fragment are the major end products; whereas in melanotropes ACTH is processed further into α-MSH and corticotropin-like intermediate peptide (CLIP), and β-LPH is processed almost completely into β-endorphin (Fig. 1) (Eipper and Mains, 1980; Rosa et al., 1980; Chretien et al., 1989). In addition, POMC is produced in the arcuate nucleus of the hypothalamus, and the POMC products produced there are similar to those of the melanotropes. Thus there is tissue-specific processing of this common precursor. Tissue-specific processing also occurs in the case of the processing of proglucagon and prosomatostatin (Dickerson and Noel, 1991).

Fig. 1

(a) The molecular structure of POMC. Paired basic residues (e.g., KR) indicate cleavage sites where each peptide is released. In the N-terminal region, 2 disulfide bonds are present. Diamonds and circles indicate N-glycosylation and O-glycosylation sites, respectively. Paired basic residues in square brackets are missing in rat and mouse. K: lysine; R: arginine. SIG: signal peptide; NPP: N-terminal peptide of POMC; JP: joining peptide; CLIP: corticotropin-like intermediate peptide; LPH: lipotropic hormone; END: endorphin; ABI: ACTH-biosynthetic intermediate. (b) Tissue-specific processing of POMC by PC1 and PC2. The numbers indicate the sequence of the processing steps. Proteolytic processing of the corticotrope type or the melanotrope type is achieved by the cleavage-specificity of PC1 and PC2. Whether the processing steps indicated in square brackets occur or not depends on the animal species. These cleavages are presumed to be made by PC2, but this has not yet been determined.

i0289-0003-20-10-1183-f01.gif

Both PC1 and PC2 are expressed in endocrine and neuroendocrine cells and cleave at paired basic residues of prohormones. The cleavage-specificity of PC1 and PC2 in POMC processing was revealed by cellular transfection experiments: PC1 cleaves POMC into ACTH and β-LPH, whereas PC2 subsequently cleaves ACTH and β-LPH to α-MSH and β-endorphin, respectively (Benjannet et al., 1991; Thomas et al., 1991). This finding was confirmed by another experiment (Zhou et al., 1993): when antisense PC1 cRNA was introduced into AtT-20 cells, a mouse corticotrope tumor cell line, the production of ACTH was inhibited. On the other hand, α-MSH was newly cleaved from ACTH when the cells were transfected with the PC2 gene. In addition to these data, histological evidence supports this differential processing: PC1 was expressed in corticotropes, whereas both PC1 and PC2 were found in melanotropes (Seidah et al., 1991; Day et al., 1992). The tissue-specific processing of POMC is thus due to the differential expression of PC1 and PC2 in these 2 cell types (Fig. 1). Such roles for these convertases were confirmed by the generation and analysis of PC1 or PC2 null mice (Laurent et al., 2002; Zhu et al., 2002).

In POMC cells of the amphibian pituitary gland, however, PC1 and PC2 do not always display the cell-specific expression observed in mammals (Kurabuchi and Tanaka, 1997). In the pars distalis, immunoreactivity of the convertases showed a different pattern among several anuran amphibians: both PC1 and PC2 were observed in the corticotropes in Rana brevipoda porosa, whereas either PC1 or PC2 was found in these cells in other species; although PC2-immunopositive cells did not express α-MSH (Kurabuchi and Tanaka, 1997). Moreover, a considerable amount of N-terminal peptide of POMC not containing γ-MSH, which is present only in the pars intermedia of mammals, was purified from the pars distalis of the adult bullfrogs (Iwamuro et al., 1992). If this peptide was generated as in the same way as in the pars intermedia (Ekman et al., 1981), PC2 would have to be present in the bullfrog pars distalis. It remains, accordingly, unsolved whether the cleavage-specificity of the prohormone convertases in amphibians is similar to that in mammals. This issue is of interest for the field of comparative endocrinology.

Comparative aspect of prohormone convertases

In a recent study, we created a cDNA library from bullfrog (Rana cabesbeiana) pituitary glands to clone and sequence 2 cDNAs encoding PC1 and PC2 (Yaoi et al., 2003). Both PCs were structurally characterized as having a signal peptide, a prosegment, a catalytic region, a P-domain, and a variable C-terminal region (Figs. 2 and 3). The predicted amino acid sequence of these PCs showed high homology with the corresponding sequences of various other species. The bullfrog PC1 cDNA was predicted to encode a 736-amino acid protein with a putative 26-residue signal peptide; and the PC2 one, a 638-amino acid protein with a putative 23-residue signal peptide. It has been shown that PCs are first synthesized as inactive precursor enzymes, which undergo autocatalytic excision or furin-dependent cleavage of their N-terminal prosegment via cleavage at a specific Arg-Arg-Ser-Arg-Arg and Arg-SerLys-Arg in the PC1 protein, and at Lys-Arg-Arg-Arg and ArgLys-Lys-Arg in the PC2 protein (Muller and Lindberg, 1999). Although there are 2 possible cleavage sites in the prosegment of both bullfrog PCs, the actual sites are considered to be Arg-Thr-Lys-Arg110 in the PC1 protein and Arg-Lys-LysArg109 in the PC2 protein, because these sites correspond to the cleavage sites of prosegment in mammalian PCs (Benjannet et al., 1992; Zhou and Lindberg, 1993). The mature PC1 protein contains 626 amino acids with 2 putative N-glycosylation sites, whereas the mature PC2 one contains 529 amino acids with 3 such sites. The catalytic domain is well conserved, especially in the regions surrounding the catalytic triad of PC1 (Asp168, His209, and Ser383) and of PC2 (Asp167, His208, and Ser384). In the P-domain of both PCs, the canonical integrin binding Arg-GlyAsp sequence is also present, as found in all mammalian convertases except PC7 (Seidah and Cretien, 1992; Seidah et al., 1996) though this sequence is absent from the PC2 protein of Rana ridibunda (Vieau et al., 1998).

Fig. 2

Comparison of the predicted amino-acid sequence of the bullfrog (Rana catesbeiana) PC1 with those sequences of other vetebrates PC1s. The amino acid residues that match those of bullfrog PC1 are shown as dots. Gaps, indicated by dashed lines, have been introduced to obtain maximum homology. The underlined letters indicate the amino acids comprising the signal peptide sequence. The putative cleavage site of prosegment indicates by arrow. Catalytic region and P-domain are enclosed by black and gray boxes, respectively. Diamonds indicate Asp, His, and Ser of active site of catalytic region. Canonical integrin binding sequence indicates by asterisks. The sequence for Rana ridibunda (Gangnon et al., 1999), human (Creemers et al., 1992), mouse (Seidah et al., 1991), rat (Hakes et al., 1991), anglerfish (Roth et al., 1993), Amphioxus (Oliva et al., 1995), Aplysia (Gorham et al., 1990), and Hydra (Chan et al., 1992) PC1s are shown. From Yaoi et al. (2003).

i0289-0003-20-10-1183-f02.gif

Fig. 3

Comparison of the predicted amino-acid sequence of the bullfrog (Rana catesbeiana) PC2 with those sequences of other vetebrates PC2s. The amino acid residues that match those of bullfrog PC2 are shown as dots. Gaps, indicated by dashed lines, have been introduced to obtain maximum homology. The underlined letters indicate the amino acids comprising the signal peptide sequence. The putative cleavage site of prosegment indicates by arrow. Catalytic region and P-domain are enclosed by black and gray boxes, respectively. Diamonds indicate Asp, His, and Ser of active site of catalytic region. Canonical integrin binding sequence indicates by asterisks. The sequence for Rana ridibunda (Vieau et al., 1998), Xenopus (Braks et al., 1992), human (Smeekens et al., 1990), mouse (Seidah et al., 1991), rat (Hakes et al., 1991), Amphioxus (Oliva et al., 1995), ascidian (AB086187), Aplysia (Chun et al., 1994), and snail (Smit et al., 1992) PC2s are shown. From Yaoi et al. (2003).

i0289-0003-20-10-1183-f03.gif

The amino acid sequence homology between the bullfrog PC1 and R. ridibunda (Gangnon et al., 1999), human (Creemers et al., 1992), mouse (Seidah et al., 1991), rat (Hakes et al., 1991), anglerfish (Roth et al., 1993), Amphioxus (Oliva et al., 1995), Aplysia (Gorham et al., 1990), and Hydra (Chan et al., 1992) PC1 was 95.6%, 62.7%, 67.2%, 66.8%, 68.1%, 56.1%, 53.5%, and 41.5%, respectively. Similarly, the amino acid sequence homology between the bullfrog PC2 and R. ridibunda (Vieau et al., 1998), Xenopus (Braks et al., 1992), human (Smeekens et al., 1990), mouse (Seidah et al., 1991), rat (Hakes et al., 1991), Amphioxus (Oliva et al., 1995), ascidian (AB086187), Aplysia (Chun et al., 1994), and snail (Smit et al., 1992) PC2 was 95.5%, 90.4%, 85.9%, 84.2%, 84.2%, 71.6%, 64.6%, 60.2%, and 61.0%, respectively.

In Amphioxus, a primitive chordata, PC1 and PC2 mRNAs are distributed thought the body, but the expression ratio of PC1 and PC2 varied depending upon the body region: 1:1 in the cranial region, 5:1 in the mid-body region, and 1:5 in the caudal region (Olviva et al., 1995). Amphioxus PC1 and PC2 are considered to be involved in the processing of many neuropeptides including pro-insulin-like peptide (a homologue of mammalian insulin/insulin-like growth factor), but the substrate-specificity of these convertases and their exact expression sites are not fully documented. Because it is known that Amphioxus has Hatschek's pit organ, which is regarded as being an adenohypophyseal homologue, it is interesting to consider whether Hatschek's pit organ expresses prohormone convertases. This issue remains to be solved.

In the ascidian Halocynthia roretzi, immunohistochemistry using mammalian PC1 and PC2 antisera demonstrated that both convertases are present in some nerve cells in cerebral ganglon and dorsal strand (Kawahara et al., 2003). Because POMC-derived peptides are also produced in the cerebral ganglon and dorsal strand (Kawahara et al., 2003), PC1 and PC2 may be involved in POMC processing as well as higher vertebrates. Recent study isolated a PC2 cDNA clone (AB086187) with its amino acid sequence showing approximately 65% homology with the sequences of vertebrate PC2 cDNAs, but PC1 cDNA has not yet cloned. Furthermore, two forms of GnRH, namely tGnRH-I and tGnRH-II, were isolated from the neural complex of the ascidian Chelyosome productum (Powell et al., 1996). In vertebrates, PC2 has been postulated as a candidate enzyme for pro-GnRH processing (Wetsel et al., 1995). Consequently, it is important to search localization of ascidian PC2 mRNA and tGnRHs in the neural complex for determining the substrate-specificity of PC2.

Hydra PC1 is expressed predominately in nerve cells of the body column, but some other nerve cells in the head and peduncle regions react with antisera against Arg-Phe-NH2, cholecystokinin, substance P, neurokinin, and oxytocin (Chan et al., 1992). It seems likely that the Hydra head and peduncle regions contain a PC1-like molecule, but this molecule has not yet been identified in these regions.

In the Moluscus, Aplysia PC1 and PC2 have been identified using the cDNA cloning (Ouimet et al., 1993; Chun et al., 1994; Gorham et al., 1996). These convertases play an important role in the processing of the egg-laying hormone precursor that is synthesized in the neuroendocrine bag cells and in the processing of egg-laying hormone-related precursors in the atrial gland, an exocrine organ. In the snail, on the other hand, expression of PC2 mRNA is restricted to the nerve cells of the cerebral ganglia that express a variety of prohormones and neuropeptides including APGWamide and moluscan insulin-related peptides (Smit et al., 1992). The fact that many efforts to demonstrate the existence of snail PC1 have failed raises the possibility that the PC1 molecule is not present in the snail. Considering that Aplyisa and the snail belong to the same phylum, Moluscus, the possible lake of PC1 in the snail generates an interesting idea concerning their evolution: that the snail lost a PC1-like convertase as these two species evolved along separate paths (Spijker et al., 1999).

By the use of RT-PCR, both bullfrog PC1 and PC2 mRNAs were found to be expressed in the pars distalis, pars neurointermedia, brain, and pancreas of the bullfrog (Yaoi et al., 2003). This finding is mostly consistent with the reports concerning mammalian species (Seidah et al., 1990; Vieau et al., 1998; Gangnon et al., 1999). It is of interest that only PC1 mRNA was expressed in the bullfrog stomach and intestine, whereas PC2 mRNA was the only type in the testis. The expression of PC1 mRNA may be involved in the processing of the intestinal type of proglucagon (Dhanvantari et al., 1996) and in the processing of progastrin in the stomach (Macro et al., 1996), whereas the PC2 may have some effect on the posttranslational processing in the bullfrog testis. However, considering that only PC4 has been identified in the mammalian testis (Nakayama et al., 1992; Seidah et al., 1992; Mbikay et al., 1999; Li et al., 2000), it is possible that the PC related with PC4 is present in the bullfrog testis. Further studies are necessary to identify another type of PC in the frog testis, and to compare substrate-specificity between PC2 and PC4. Although PC2 mRNA has been detected in the pars distalis of the adult bullfrog by RTPCR, it appears that PC2 mRNA was not translated there, because PC2 protein is not detected in the pars distalis by immunohistochemical staining (Kurabuchi and Tanaka, 1997) or by in situ hybridization (Yaoi et al., 2003).

Using in situ hybridization, Yaoi et al. (2003) found PC1 mRNA to be expressed in the pars distalis and the pars intermedia, but detected PC2 mRNA only in the pars inter-media, of the adult bullfrog. Similar results were obtained with Rana ridibunda (Vieau et al., 1998; Gangnon et al., 1999). An in situ hybridization experiment with the antisense RNA of Xenopus PC2 also revealed that PC2 mRNAs were predominantly expressed in the pars intermedia of the Xenopus pituitary (Braks et al., 1992). The expression pattern of PC1 and PC2 mRNAs in the bullfrog pituitary is also in good agreement with the immunohistochemical findings showing that the pars distalis expressed PC1 protein and the pars intermedia contains both PC1 and PC2 proteins (Kurabuchi and Tanaka, 1997). In addition, in the latter the degree of expression of PC2 was higher than that of PC1, being consistent with data from mammals (Day et al., 1992). Interestingly, PC2 mRNA was expressed in the α-MSH-positive corticotropes of the bullfrog tadpole. In mammals, it is known that, during development, PC2 mRNA is also expressed in corticotropes in the pars distalis until neonatal week 3, thereby producing α-MSH (Marcinkiewicz et al., 1993). The α-MSH is considered to have stimulatory effects on intrauterine growth (Swaab et al., 1976) and growth-stimulating effects on the adrenal zona glomerulosa (Robba et al., 1986). However, the exact role of α-MSH during development remains unclarified. Similarly, in the urodele amphibian Ambystoma, corticotropes produce α-MSH during the larval period (Dores et al., 1989, 1990, 1993). The production of α-MSH during the neonatal period or larval period is considered to be a general phenomenon, and to vary with fluctuation in PC2 expression. However, no PC2 mRNA was detected by in situ hybridization in corticotropes of the adult bullfrogs, although α-MSH-immunoreactivity was detected in these cells (Yaoi et al., 2003). This may imply that very little PC2 mRNA is translated or that α-MSH, which had been produced at larval stages, remained stored in the secretory granules. In this connection, α-MSH was found in some of the ACTH-positive secretory granules in corticotropes of the adult rat (Tanaka and Kurosumi, 1986), implying that PC2 was sorted to certain secretory granules.

An in situ hybridization study showsed that PC1 mRNA was expressed in the gonadotropes of the bullfrog (Yaoi et al., 2003). It is conceivable that proprotein processing does not take place in these cells. However, it is possible that other proteins such as granin family proteins with proteolytic cleavage sites are contained in the secretory granules and that these proteins are cleaved by PC1. Indeed, Uehara et al. (2001) reported that both PC1 and PC2 were expressed in the rat pituitary gonadotrope, suggesting that PC2 may be involved in the proteolytic processing of secretogranin II and that both PC1 and PC2 may be necessary to process chromogranin A (CgA).

Further processing of peptide hormones for expression of biological activity

Following processing by PC1 and/or PC2, peptide hormones have 2 basic residues at their C-terminus. These paired basic residues are removed by carboxylpeptidase E (CPE), which thereby produces the active forms of some peptides (Fig. 4) (Fricker et al., 1991). Some other peptide hormones are activated by further modification such as amidation at the C-terminus or acetylation at the N-terminus. The modification of peptide hormones by these enzymes is an important step for activating them. For example, α-MSH, which is involved in background-adaptation by causing a change in skin-color, occurs in 2 forms: acetylated and nonacetylated forms. In Xenopus laevis, skin-color is mainly regulated by the biologically active form, acetylated α-MSH; whereas in the lizard Anolis carolinensis, the skin-color is regulated by a large amount of non-acetylated α-MSH having low potency and a short half-life. By utilizing nonacetylated α-MSH, Anolis seems to respond rapidly for the background-light (Dores et al., 1994). In contrast, when β-endorphin is acetylated, the opiate activity of this peptide is completely eliminated (Smyth et al., 1979; Deakin et al., 1980). Interestingly, neuronal cells secrete non-acetylated β-endorphin, whereas cells in the pars intermedia secrete acetylated β-endorphin (Jenks et al., 1988).

Fig. 4

Proteolytic cleavage stages of POMC to α-MSH.

i0289-0003-20-10-1183-f04.gif

Recently, it was reported that a point mutation in the CPE gene causes the genetic disorder of obesity in fat/fat mice (Naggert et al., 1995). Because in the fat/fat mouse Ser substitutes for Pro at residue 202 in CPE, the mutant CPE does not have normal enzyme activity, thereby producing insulin intermediates retaining their paired basic residues. As a result, the mouse secretes inactive insulin and develops an obesity/diabetes. Song and Fricker (1995) noticed that carboxylpeptidase-like activity did not completely disappear in the fat/fat mouse, and then identified a new carboxylpepidase, carboxylpeptidase D, as being responsible for the residual activity. In the fat/fat mouse, this enzyme presumably compensates for the inactive CPE.

In which intracellular sites does the proteolytic cleavage occur?

The biosynthesis and processing of peptide hormones take place along the secretory route of the prohormone from the rough-endoplasmic reticulum, the site of synthesis, to the trans-Golgi network (TGN), similar to the case of other secretory proteins. At the TGN, peptide hormones are segregated from the other proteins, such as lysosomal enzymes and constitutive secretory proteins including plasma membrane proteins. The immunocytochemical identification of start and end sites of the cleavage on the same cell sections is of considerable importance for a proper understanding of the mechanism of processing. In POMC processing, Tooze et al. (1987) showed, by using an antibody that was able to specifically recognize a cleavage site of POMC, that some POMC was packaged into secretory granules prior to its cleavage. On the other hand, Schnabel et al. (1989) concluded that processing of POMC began in the trans-most cisterna of the Golgi apparatus based on their detection of processed products in this compartment. However, neither study examined whether or not both the precursor and mature peptides were present in the same compartments in POMC cells. Addressing this point by using antibodies specific for the cleavage site of POMC and for a mature peptide [amidated joining peptide (JP)], we detected both the precursor POMC and amidated JP in the same secretory granule in POMC cells (Fig. 5) (Tanaka and Kurosumi, 1992; Tanaka et al., 1997). The corticotropes of the adult rat pituitary have 2 distinct types of secretory granules, i.e., small electron-dense and large electron-lucent ones. The former was found not only near the Golgi apparatus, but also among the peripheral secretory granules arranged in a single row along the cell membrane. The latter was observed mainly among the peripheral secretory granules. POMC was localized in the electron-dense secretory granules, whereas amidated JP was found in the electron-lucent secretory granules in the same ultrathin cryosections (Fig. 6). Colocalization of POMC and its cleaved peptides in the same secretory granules was rarely observed. Only POMC immunolabeling was detected in the Golgi cisternae. In AtT-20 cells, POMC was detected predominantly in the secretory granules around the Golgi apparatus and in condensing secretory materials on the rims of the trans-Golgi cisternae, whereas amidated JP was predominant in the secretory granules at the tips of the cell processes. Actually, both PC1 and PC2 were found in secretory granules of pituitary POMC cells (Kurabuchi and Tanaka, 1997; Tanaka et al., 1997) and pancreatic endocrine cells (Malide et al., 1995; Tanaka et al., 1996). In addition, POMC and α-MSH appear in separate secretory granules in melanotropes of the adult rat (Tanaka et al., 1991), and POMC is therefore thought to be cleaved mainly in secretory granules coordinately with their maturation.

Fig. 5

Immunofluorescence images showing localization of POMC and amidated joining peptide (JP) in the pituitary gland (a, b) and AtT-20 cells (c, d). Both POMC and amidated JP (arrowheads) are visible throughout the cytoplasm in several corticotropes (a, b), whereas POMC (arrows) is visible as a strong spot in the perinuclear region in melanotropes (a). PD: the pars distalis; PI: the pars intermedia. In AtT-20 cells, the intense staining for POMC (arrow) is found exclusively in the Golgi region (c), and the punctate staining for amidated JP (arrowheads) is distributed at the tips of cell processes (d). The blue color is nuclear DNA stained with DAPI. Bar: a, b=20 μm, c, d=20 μm. c, d from Tanaka et al. (1997).

i0289-0003-20-10-1183-f05.jpg

Fig. 6

Immunoelectron micrograph showing localization of POMC and amidated joining peptide (JP) in the rat corticotrope cells. Two kinds of secretory granules, dense (arrowheads) and lucent ones (arrows), are visible. Large immunogold particles indicating the presence of POMC are visible in both the Gogli cisternae and the dense granules, while small particles indicating the presence of amidated JP are predominately in the lucent granules. G: the Golgi apparatus, M: mitochondria, CM: cell membrane. Bar=0.2 μm. From Tanaka et al. (1997).

i0289-0003-20-10-1183-f06.gif

Acidified secretory granules provide the proper environment for activating PC1 and PC2

Enzymological studies have shown that the prohormone convertases PC1 and PC2 are most active at a relatively acidic pH, i.e., pH 5.0 - 6.5 (Davidson et al., 1988; Rufaut et al., 1993; Zhou and Lindberg, 1993; Lamango et al., 1996); whereas furin, which is localized mainly in the TGN and is involved in the cleavage of precursors for constitutively secreted proteins and plasma membrane proteins rather than prohormones, has a neutral pH optimum (Hatsuzawa et al., 1992; Molloy et al., 1992, 1994). These facts indicate that there may be a close relationship between the optimum pH of the enzymes and their subcellular localization. It is therefore important to know whether or not the pH of secretory granules is adequate for the action of prohormone convertases. Elegant studies by Orci et al. (1986, 1987, 1994) using DAMP [3-(2,4-dinitroanillino)-3′amino-Nmethyldipropylamine] as a pH probe showed that in pancreatic β-cells, conversion of proinsulin to insulin occurred coordinately with the acidification of maturing secretory granules. Similarly, Tanaka et al. (1997) demonstrated, also using the DAMP method, that in AtT-20 cells the granular pH varied from one granule to another over a range of 5.2 to 7.0. These granular pH values are in good agreement with those for granules in pancreatic β-cells reported by Orci et al. (1986, 1987, 1994). Moreover, there was a tendency that the labeling density for DAMP correlated negatively with that for POMC, and positively with that for amidated JP (Figs. 7 and 8) (Tanaka et al., 1997). Taken together with the observations of the colocalization of POMC and amidated JP in the same granule noted above, POMC processing in AtT-20 cells is presumed to occur mainly in acidifying secretory granules.

Fig. 7

Localization of DAMP (small gold particles) and POMC (large gold particles) (a), and of DAMP (small gold particles) and amidated JP (large gold particles) (b) on the same ultrathin sections of AtT-20 cells. The labeling density of DAMP was lower in POMC-positive granules than in amidated JP-positive granules. Arrowheads: secretory granules, M: mitochondria, N: nucleus. Bar=0.25 μm. From Tanaka et al. (1997).

i0289-0003-20-10-1183-f07.gif

Fig. 8

The relationship between DAMP accumulation and proteolytic cleavage of POMC. There is (a) a slight negative correlation between DAMP and POMC labeling and (b) a slight positive correlation between DAMP and amidated JP labeling. The rate of proteolytic cleavage of POMC to amidated JP increases in correlation with the acidification of secretory granules. The pH values are estimated from the incorporation of DAMP. Modified after Tanaka et al. (1997).

i0289-0003-20-10-1183-f08.gif

Nelson and Taiz (1989) discovered that the internal acidic environment in the secretory pathways was generated by a vacuolar-type-H+-ATPase (V-ATPase). V-ATPase was later purified from the Golgi apparatus (Moriyama and Nelson, 1989) and secretory granules (Moriyama and Futai, 1990) and characterized. From various experiments, VATPase was found to play an important role in intracellular processes such as trafficking, endocytosis, recycling, hydrolysis and secretion of protein in addition to the processing of proteins. The V-ATPase molecule is organized into 2 main parts (Schoonderwoert and Martens, 2001): a cytoplasmic ball-like structure (V1) and a membrane sector (V0) bridged by a cytoplasmic stalk. The peripheral catalytic V1 sector (molecular mass of ∼840 kDa) is responsible for the hydrolysis of ATP, whereas the 260-kDa integral V0 sector is responsible for proton translocation across the membrane. The V1 sector consists of 8 different subunits (A–H). The V0 sector is formed by 5 different subunits, namely, subunits a and d, and proteolipids c, c′, and c”. Because VATPase is made of multi-components, proper assembly of these subunits is required to drive the proton pump. Consequently, it will be a challenging issue to elucidate the regulatory mechanism of its assembly.

Bafilomycin A1 is known to be a specific inhibitor of VATPase in chromaffin granules, lysosomes and the Golgi apparatus (Bowman et al., 1988; Moriyama and Nelson, 1989), and the application of bafilomycin A1 would therefore be expected to define the role of V-ATPase-mediated acid-ification in the secretory pathways. Pulse-chase experiments have shown that bafilomycin A1 inhibited POMC processing, and electron microscopic analysis detected POMC, but not amidated JP, in bafilomycin A1-treated cells (Tanaka et al., 1997). Since in the drug-treated cells the accumulation of DAMP in granules was blocked to background levels, it appears that the V-ATPase inhibitor neutralized the granules, thereby inhibiting POMC processing. On the other hand, Mains and May (1988) reported that chloroquine, which also dissipates intracellular acidic environments, but by a mechanism different from that of bafilomycin A1, did not inhibit POMC processing. These data indicate that a acidic environment is not essential for the processing of POMC by PC1. This view is indirectly supported by enzymological studies showing that although PC1 has an acidic pH optimum, it still exhibited some activity around neutral pH (Davidson et al., 1988; Rufaut et al., 1993; Zhou and Lindberg, 1993), and is in line with the data of Schnabel et al. (1989) showing that POMC processing began in the TGN. Certainly, the data described above clearly demonstrate that proteolytic processing of POMC in AtT-20 cells occurs coordinately with the maturation of secretory granules.

Regulation of the activation of prohormone convertase

Because the precursors of PC1 and PC2 are present and become active forms after the cleavage of their prosegment, this process is considered to be involved in the regu-lation of prohormone processing (Muller and Lindberg, 1999). Pro-PC1 proteins are transformed into their active forms within several min, whereas the transformation of proPC2 proteins into their active forms requires 1–2 hr (Zhou and Mains, 1994). The 7B2 protein was found to participate as a chaperone in the regulation of PC2 activation and to control the timing for activating the convertase (Martens et al., 1994). 7B2 is a member of the granin family of acidic, neuroendocrine-specific secretory granule proteins that include chromogranin A and secretogranin II (Huttner et al., 1991; Mbikay et al., 2001). Because 7B2 was expressed in parallel with the expression of POMC in Xenopus melanotrope cells of the pars intermedia, this protein was proposed to act in some way in the regulation of the secretory pathway (Ayoubi et al., 1991).

First, it was found that human 27kD-7B2, produced by the use of recombinant DNA techniques, inhibited PC2 activity but that the 21-kD form of 7B2 did not have such an activity (Braks and Martens, 1994; Martens et al., 1994). Second, 27-kD 7B2 makes molecular complexes by specific binding to pro-PC2 (75 kD) in the endoplasmic reticulum, which complexes are then transferred to the Golgi apparatus (Braks and Martens, 1994; Benjannet et al., 1995). These molecular complexes, cleaved by furin or PACE4 in the TGN, are partially dissociated after the 27-kD 7B2 form is split into 21-kD 7B2 and a C-terminal domain known as the CT peptide (Paquet et al., 1994). The N-terminal 21-kD portion then dissociates from the pro-PC2, whereas the CT peptide remains bound to it. In the proper intracellular sites for PC2 activity, probably immature secretory granules, the CT peptide is further processed and then dissociates from pro-PC2 (Zhu et al., 1996; Muller and Lindberg, 1999). At this time, pro-PC2 is cleaved by autolysis, and then converted to the active PC2 form (Fig. 9).

Fig. 9

Activation mechanisms of PC1 and PC2 and proteolytic processing of POMC. Refer to the text for details.

i0289-0003-20-10-1183-f09.gif

On the other hand, PC1 is transformed to its active form autocatalytically in the endoplasmic reticulum after production as a 92–94 kD pro-form (Benjannet et al., 1993; Lindberg, 1994; Milgram and Mains, 1994). Consequently, association of the 27-kD 7B2 protein with pro-PC2 is considered to be a safety system for inhibiting the precocious activation of PC2. This delay in activating PC2 is thus an ingenious system with respect to the order of proteolytic cleavage of pro-hormones such as POMC and proinsulin. In addition, recent studies suggest that proSAAS, a granin family protein that is broadly distributed in neuroendocrine tissues, is a natural inhibitor of PC1, similar to the situation of 7B2 and PC2 (Fricker et al., 2000; Basak et al., 2001).

Recently, 7B2 null mice have been generated by using a novel transposon-based technique (Westphal et al., 1999). In the pituitary of these mice, inactive PC2 fails to generate α-MSH in the pars intermedia, resulting in a very high level of intact ACTH in this lobe that resembles pituitary Cushing's disease. In the neurointermediate lobe, secretion of POMC-related peptides is negatively controlled by dopamine. Interestingly, the 7B2 null mice contain only a quarter of the normal levels of dopamine, but adrenalectomy of 3-week-old mice induces normal levels of dopamine, rescuing these animals from the lethal phenotype. It is presumed that a diminished pool of dopamine in the nerve endings in the neurointermediate lobe in the 7B2 null might be involved in the enhanced secretion of ACTH (Laurent et al., 2002).

Prohormone sorting and secretory granule formation

Because prohormones are sorted to the regulated pathway at the TGN and packaged into secretory granules, the sorting event is closely linked to the formation of secretory granules. Two models have been proposed for the mechanism underlying this process (Halban and Irminger, 1994; Cawley et al., 1998; Teter and Moore, 1998). One is an aggregation passive sorting model in which the proteins, by forming a condensing aggregate, are trapped and packaged into the granules. The other is the sorting signal ligand-receptor model in which a sorting signal in the prohormone binds to a receptor located in the lumen of the TGN, which binding is followed by budding of the TGN and formation of an immature granule encapsulating the proteins destined for the regulated secretory pathway. In mammalian cells, evidence has accumulated that various hormones and granin proteins aggregate at the TGN under conditions of mildly acidic pH and high Ca2+ (Gerdes et al., 1989; Yoo et al., 1995; Colmer et al., 1996; Yoo and Lewis, 1996; Jain et al., 2000). If regulated secretory proteins are condensed at the TGN and constitutive secretory proteins remain dissolved as single molecules, self-aggregation may induce the sorting of the hormones to the regulated secretory pathway. On the other hand, Cool et al. (1995) found that the hairpin loop formed by disulfide bridges is important for the sorting to the regulated pathway and demonstrated that POMC was diverted to the constitutive pathway when this disulfide bridge was broken. Using radio-labeled N-POMC fragments including the N-terminal hairpin loop in POMC, Cool et al. (1997) identified a protein showing specific binding to NPOMC peptides from membranes of the TGN or secretory granules, and then identified this protein to be CPE. They provided evidence that when antisense CPE RNA was introduced into POMC-expressing Neuro-2a cells, POMC-derived peptides were sorted to the constitutive pathway, but not to the regulated pathway. This finding was confirmed by evidence that POMC-derived peptides are sorted to the constitute pathway in the fat/fat mouse having a mutation in CPE. These data suggest that CPE plays a role as a sorting receptor at the TGN. However, because not all prohormones have a hairpin loop structure similar to POMC, it remains to be determined whether this loop structure-CPE receptor hypothesis is generally applicable.

Recently, Kim et al. (2001) suggested that CgA, which is an acidic sulfated glycoprotein, could act as an on/off switch in endocrine cells to trigger or block secretory granule biogenesis. Using the antisense RNA strategy, they examined the effect of specific depletion of CgA on dense-core secretory granule formation in PC12 cells, a model neuroendocrine cell line. As a result, CgA-deficient PC12 cells showed a decreased number of dense-core secretory granules; whereas transfection of a CgA-deficient pituitary cell line, 6T3, with CgA mRNA restored regulated secretion. However, this proposed function is not consistent with evidence showing that secretory granules exist in the absence of CgA and that cells can synthesize CgA in the absence of secretory granules (Day and Gorr, 2003). Day and Gorr (2003) suppose that CgA might act as an assembly factor in this process.

CONCLUSION

During the last decade, considerable progress has been made concerning the molecular identity of prohormone convertases, as well as elucidation of the molecular mechanism underlying intracellular processing. Secretory granules in endocrine and neuroendocrine cells have been found to function as proper sites for biosynthesis of hormones in addition to serving as storage sites and vehicles for the transport of peptide hormones. There yet remain unanswered questions about the mechanism of secretory granule formation. However, in the near future these issues are expected to be resolved.

Acknowledgments

We thank Prof. Gerard J.M. Martens of the Department of Molecular Animal Physiology, University of Nijmegen for very thorough reading of the manuscript and many helpful suggestions and Dr. Masakazu Suzuki of our laboratory for helpful discussions. This study was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.

REFERENCES

1.

T. A. Y. Ayoubi, H. L. P. van Duijnhoven, A. J. M. Coenen, B. G. Jenks, E. W. Roubos, and G. J. M. Materns . 1991. Coordinated expression of 7B2 and αMSH in the melanotrope cells of Xenopus laevis. Cell Tissue Res 264:329–334. Google Scholar

2.

A. Basak, P. Koch, M. Dupelle, L. D. Fricker, L. A. Devi, M. Chretien, and N. G. Seidah . 2001. Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1. J Biol Chem 276:32720–32728. Google Scholar

3.

S. Benjannet, N. Rondeau, R. Day, M. Chretien, and N. G. Seidah . 1991. PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues. Proc Natl Acad Sci USA 88:3564–3568. Google Scholar

4.

S. Benjannet, T. Reudelhuber, C. Mercure, N. Rondeau, M. Chretien, and N. G. Seidah . 1992. Proprotein converson is determined by a multiplicity of factors including convertase processing, substrate specificity, and intracellular environment. Cell type-specific processing of human prorenin by the convertase PC1. J Biol Chem 267:11417–11423. Google Scholar

5.

S. Benjannet, N. Rondeau, L. Paquet, A. Boudreault, C. Lazure, M. Chretien, and N. G. Seidah . 1993. Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2. Biochem J 294:735–743. Google Scholar

6.

S. Benjannet, D. Savaria, M. Chretien, and N. G. Seidah . 1995. 7B2 is a specific intracellular binding protein of the prohormone convertase PC2. J Neurochem 64:2303–2311. Google Scholar

7.

E. J. Bowman, A. Siebers, and K. Altendorf . 1988. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Sci USA 85:7972–7976. Google Scholar

8.

J. A. M. Braks, K. C. W. Guldemond, M. C. H. M. van Riel, A. J. M. Coenen, and G. J. M. Martens . 1992. Structure and expression of Xenopus prohormone convertase PC2. FEBS Lett 305:45–50. Google Scholar

9.

J. A. M. Braks and G. J. M. Martens . 1994. 7B2 is a neuroendocrine chaperone that transiently interats with prohormone convertase PC2 in the secretory pathway. Cell 78:263–273. Google Scholar

10.

M. Chretien, R. Sikstrom, C. Lazure, M. Mbikay, S. Benjannet, M. Marcinkiewicz, and N. G. Seidah . 1989. Expression of the diversity of neural and hormonal peptides via the cleavage of precursor molecules. In “Peptide Hormones as Prohormones Processing, Biological Activity, Pharmacology”. Ed by J. Martinez Ellis Horwood Ltd. Chichester. pp. 1–25. Google Scholar

11.

N. X. Cawley, D. R. Cool, E. Normant, F-S. Shen, V. Olsen, and Y. P. Loh . 1998. The mechanism of sorting proopiomelanocortin to secretory granules and its processig by aspartic and PC enzymes. In “Proteolytic and Cellular Mechanisms in Prohormone and Proprotein Processing”. Ed by V. Y. H. Hook RG Landes Company. Austin. pp. 29–48. Google Scholar

12.

S. J. Chan, J. A. O. Oliva, J. LaMendola, A. Grens, H. Bode, and D. F. Steiner . 1992. Conservation of the prohormone convertase gene family in metazoa: analysis of cDNA encoding a PC3-like protein from hydra. Proc Natl Acad Sci USA 89:6678–6682. Google Scholar

13.

J. Y. Chun, J. Korner, T. Kreiner, R. H. Scheller, and R. Axel . 1994. The function and differential sorting of a family of Aplysia prohormone processing enzymes. Neuron 12:831–844. Google Scholar

14.

V. Colomer, G. A. Kicska, and M. J. Rindler . 1996. Secretory granule content proteins and the luminal domains of granule membrane proteins aggregate in vitro at mildly acidic pH. J Biol Chem 271:48–55. Google Scholar

15.

D. R. Cool, M. Fenger, C. R. Snell, and Y. P. Loh . 1995. Identification of the sorting signal motif within pro-opiomelanocortin for the regulated secretory pathway. J Biol Chem 270:8723–8729. Google Scholar

16.

D. R. Cool, E. Normant, F-S. Shen, H-C. Chen, L. Pannell, Y. Zhang, and Y. P. Loh . 1997. Carboxypeptidase E is a regulated secretory pathway sorting receptor: genetic obliteration leads to endocrine disorders in Cpefat mice. Cell 88:73–83. Google Scholar

17.

J. W. M. Creemers, A. J. M. Roebroek, and W. J. M. Van de Ven . 1992. Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3. Cloning and primary sequence of a 5 kb cDNA. FEBS Lett 300:82–88. Google Scholar

18.

R. Day, M. K-H. Schafer, S. J. Watson, M. Chretien, and N. G. Seidah . 1992. Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol Endocrinol 6:485–497. Google Scholar

19.

R. Day and S-U. Gorr . 2003. Secretory granule biogenesis and chromogranin A: master gene, on/off switch or assembly factor? Trends Endocrinol Metab 14:10–13. Google Scholar

20.

H. W. Davidson, C. J. Rhodes, and J. C. Hutton . 1988. Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic β cell via two distinct site-specific endopeptidases. Nature 333:93–96. Google Scholar

21.

J. F. Deakin, J. O. Dostrovsky, and D. G. Smyth . 1980. Influence of N-terminal acetylation and C-terminal proteolysis on the analgestic activity of β-endorphin. Biochem J 189:501–506. Google Scholar

22.

S. Dhanvantari, N. G. Seidah, and P. L. Brubaker . 1996. Role of prohormone convertases in the tissue-specific processing of proglucagon. Mol Endocrinol 10:342–355. Google Scholar

23.

I. M. Dickerson and G. Noel . 1991. Tissue-specific peptide processing. In “Peptide Biosynthesis and Processing”. Ed by L. D. Fricker CRC Press. Boca Rato. pp. 71–109. Google Scholar

24.

R. M. Dores, J. C. Meza, L. M. Schenk, J. A. Carr, and D. O. Norris . 1989. Detection of adrenocorticotropin-related and α-melanocyte-stimulating hormone-related substances in the anterior pituitary of larval and adult Ambystoma tigrinum (Class: amphibia). Endocrinology 124:1007–1016. Google Scholar

25.

R. M. Dores, L. M. Schenk, and J. Meza . 1990. Developmental changes in the processing of ACTH in the anterior pituitary of the amphibian, Ambystoma tigrinum. J Exp Zool 4:154–156. Google Scholar

26.

R. M. Dores, F. L. Sandoval, and L. K. McDonald . 1993. Proteolytic cleavage of ACTH in corticotropes of sexually mature axolotls (Ambysotoma mexicanum). Peptides 14:1029–1035. Google Scholar

27.

R. M. Dores, H. Wasinger, D. Vaudry, T. Steveson, and A. Lancha . 1994. Melanotropes of the lizard, Anolis carolinensis, lack N-acetylating mechnisms for both alpha-melanocyte-stimulating hormone and beta-endorphin. Neuroendocrinology 59:603–609. Google Scholar

28.

B. A. Eipper and R. E. Mains . 1980. Structure and biosynthesis of proadrenocorticotropin/endorphin and related peptides. Endocrine Rev 1:1–27. Google Scholar

29.

R. Ekman, R. Hakanson, and H. Jornvall . 1981. A novel N-terminal fragment of pro-gamma-melanotropin, not containing gamma-melanotropin and generated from a cleavage site lacking the traditional two basic residues. FEBS Lett 132:265–268. Google Scholar

30.

L. D. Fricker 1991. Peptide processing exopeptidases: amino- and carboxypeptidases involved with peptide biosynthesis. In “Peptide Biosynthesis and Processing”. Ed by L. D. Fricker CRC Press. Boca Raton. pp. 199–229. Google Scholar

31.

L. D. Fricker, A. A. McKinzie, J. Sun, E. Curran, Y. Qian, L. Yan, S. D. Patterson, P. L. Courchesne, B. Richards, N. Levin, N. Mzhavia, L. A. Devi, and J. Douglass . 2000. Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing. J Neurosci 20:639–648. Google Scholar

32.

R. S. Fuller, A. J. Brake, and J. Thorner . 1989. Intracellular targeting and structural conservation of a prohormone-processing endopro-tease. Science 246:482–486. Google Scholar

33.

F. Gangnon, J. M. Danger, S. Jegou, D. Vieau, N. G. Seidah, and H. Vaudry . 1999. Molecular cloning, characterization of cDNA, and distribution of mRNA encoding the frog prohormone convertase PC1. J Comp Neurol 405:160–172. Google Scholar

34.

H-H. Gerdes, P. Rosa, E. Phillips, P. A. Baeuerle, R. Frank, P. Argos, and W. B. Huttner . 1989. The primary structure of human secretogranin II a widespread tyrosine-sulfated secretory granule protein 1196 that exhibits low pH- and calcium-induced aggregation. J Biol Chem 264:12009–12015. Google Scholar

35.

E. L. Gorham, G. T. Nagle, J. S. Smith, H. Shen, and A. Kurosky . 1996. Molecular cloning of prohormone convertase 1 from the atrial gland of Aplysia. DNA Cell Biol 15:339–345. Google Scholar

36.

P. A. Halban and J-C. Irminger . 1994. Sorting and processing of secretory proteins. Biochem J 299:1–18. Google Scholar

37.

D. J. Hakes, N. P. Birch, A. Mezey, and J. Dixon . 1991. Isolation of two complementary deoxyribonucleic acid clones from a rat insulinoma cell line based on similarities to Kex2 and furin sequences and the specific localization of each transcript to endocrine and neuroendocrine tissues in rats. Endocrinology 129:3053–3063. Google Scholar

38.

K. Hatsuzawa, M. Nagahama, S. Takahashi, K. Takada, K. Murakami, and K. Nakayama . 1992. Purification and characterization of furin, a Kex2-like processing endoprotease, produced in Chinese hamster ovary cells. J Biol Chem 267:16094–16099. Google Scholar

39.

W. B. Huttner, H-H. Gerdes, and P. Rosa . 1991. The granin (chromogranin/secretogranin) family. Trends Biochem Sci 16:27–30. Google Scholar

40.

S. Iwamuro, H. Hayashi, C. Delbende, H. Vaudry, and S. Kikuyama . 1992. Purification and characterization of joining peptide and N-terminal peptide of proopiomelanocortin from the pars distalis of the bullfrog pituitary. Peptides 13:729–735. Google Scholar

41.

R. K. Jain, P. B. Joyce, and S. U. Gorr . 2000. Aggregation chaperones enhance aggregation and storage of secretory proteins in endocrine cells. J Biol Chem 275:27032–27036. Google Scholar

42.

B. G. Jenks, B. M. L. Verburg-van Kemenade, and G. J. M. Martens . 1988. Proopiomelanocortin in the amphibian pars intermedia: a neuroendocrine model system. In “The Melanotropic Peptides: Volume 1”. Ed by M. E. Hadley CRC Press. Boca Raton. pp. 103–126. Google Scholar

43.

G. Kawahara, K. Terakada, S. Tanaka, and S. Kikuyama . 2003. Occur-rence of prohormone convertase-like substances in the neural complex cells of the ascidian Halocynthia roretzi. Gen Comp Endocrinol 131:32–37. Google Scholar

44.

T. Kim, J. Tao-Cheng, L. E. Eiden, and Y. P. Loh . 2001. Chromogranin A an “on/off” switch controlling dense-core secretory granule biogenesis. Cell 106:499–509. Google Scholar

45.

S. Kurabuchi and S. Tanaka . 1997. Immunocytochemical localization of prohormone convertases PC1 and PC2 in anuran pituitary gland - subcellular localization in corticotrope and melanotrope cells. Cell Tissue Res 288:485–496. Google Scholar

46.

N. S. Lamango, X. Zhu, and I. Lindberg . 1996. Purification and enzymatic characterization of recombinant prohormone convertase 2: stabilization of activity by 21 kDa 7B2. Arch Biochem Biophys 330:238–250. Google Scholar

47.

V. Laurent, A. Kimble, B. Peng, P. Zhu, J. E. Pintar, D. F. Steiner, and I. Lindberg . 2002. Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion. Proc Natl Acad Sci USA 99:3087–3092. Google Scholar

48.

M. Li, M. Mbikay, and A. Arimura . 2000. Pituitary adenylate cyclase-activating polypeptide precursor is processed solely by prohormone convertase 4 in the gonads. Endocrinology 141:3723–3730. Google Scholar

49.

I. Lindberg 1994. Evidence for cleavage of the PC1/PC3 pro-segment in the endoplasmic reticulum. Mol Cell Neurosc 5:263–268. Google Scholar

50.

J. A. Macro, R. Dimaline, and G. J. Dockray . 1996. Identification and expression of prohormone-converting enzymes in the rat stomach. Am J Physiol 270:G87–G93. Google Scholar

51.

R. E. Mains and V. May . 1988. The role of a low pH intracellular compartment in the processing, storage, and secretion of ACTH and endorphin. J Biol Chem 263:7887–7894. Google Scholar

52.

D. Malide, N. G. Seidah, M. Chretien, and M. Bendayan . 1995. Electron microscopic immunocytochemical evidence for the involvement of the convertases PC1 and PC2 in the processing of proinsulin in pancreatic β-cells. J Histochem Cytochem 43:11–19. Google Scholar

53.

M. Marcinkiewicz, R. Day, N. G. Seidah, and M. Chretien . 1993. Ontogeny of the prohormone convertases PC1 and PC2 in the mouse S. Tanaka hypophysis and their colocalization with corticotropin and α-melanotropin. Proc Natl Acad Sci USA 90:4922–4926. Google Scholar

54.

G. J. M. Martens, J. A. M. Braks, D. W. Eib, Y. Zhou, and I. Lindberg . 1994. The neuroendocrine polypeptide 7B2 is an endogeneous inhibitor of prohormone convertase PC2. Proc Natl Acad Sci USA 91:5784–5787. Google Scholar

55.

M. Mbikay, H. Tadros, N. Ishida, C. P. Lerner, E. De Lamirande, A. Chen, M. El-Alfy, Y. Clermont, N. G. Seidah, M. Chretien, C. Gagnon, and E. M. Simpson . 1997. Impaired fertility in mice deficient for the testicular germ-cell protease PC4. Proc Natl Acad Sci USA 94:6842–6846. Google Scholar

56.

M. Mbikay, N. G. Seidah, and M. Chretien . 2001. Neuroendocrine secretory protein 7B2: structure, expression and functions. Biochem J 357:329–342. Google Scholar

57.

S. L. Milgram and R. E. Mains . 1994. Differential effects of temperture blockade on the proteolytic processing of three secretory granule-associated proteins. J Cell Sci 101:737–745. Google Scholar

58.

S. S. Molloy, P. A. Bresnahan, S. H. Leppia, K. R. Klimpel, and G. Thomas . 1992. Human furin is a calcium-dependent serine endopro-tease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267:16396–16402. Google Scholar

59.

S. S. Molloy, L. Thomas, J. K. VanSlyke, P. E. Stenberg, and G. Thomas . 1994. Intracellular trafficking and activation of the furin proprotein convertase: localization to the TGN and recycling from the cell surface. EMBO J 13:18–33. Google Scholar

60.

Y. Moriyama and N. Nelson . 1989. H+-translocating ATPase in Golgi apparatus. J Biol Chem 264:18445–18450. Google Scholar

61.

Y. Moriyama and M. Futai . 1990. Presence of 5-hydroxytryptamine (serotonin) transport coupled with vacuolar-type H+-ATPase in neurosecretory granules from bovine posterior pituitary. J Biol Chem 265:9165–9169. Google Scholar

62.

L. Muller and I. Lindberg . 1999. The cell biology of the prohormone convertases PC1 and PC2. Prog Nucleic Acid Res Mol Biol 63:69–108. Google Scholar

63.

J. K. Naggert, L. D. Fricker, O. Varlamov, P. M. Nishina, Y. Rouille, D. F. Steiner, R. J. Carroll, B. J. Paigen, and E. H. Leiter . 1995. Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 10:135–142. Google Scholar

64.

K. Nakayama, W-S. Kim, S. Torii, M. Hosaka, T. Nakagawa, J. Ikemizu, T. Baba, and K. Murakami . 1992. Identification of the fouth member of the mammalian endoprotease family homologous to the yeast Kex2 protease. J Biol Chem 267:5897–5900. Google Scholar

65.

N. Nelson and L. Taiz . 1989. The evolution of H+-ATPases. Trends Biochem Sci 14:113–116. Google Scholar

66.

L. Orci, M. Ravazzola, M. Amherdt, O. Madsen, A. Perrelet, J. D. Vassalli, and G. W. Anderson . 1986. Conversion of proinsulin to insulin occurs coordinately with acidification of maturing secretory vesicles. J Cell Biol 103:2273–2281. Google Scholar

67.

L. Orci, M. Ravazzola, M-J. Storch, R. G. W. Anderson, J-D. Vassalli, and A. Perrelet . 1987. Proteolytic maturation of insulin is a post-Golgi event which occurs in acidifying clathrin-coated secretory vesicles. Cell 49:865–868. Google Scholar

68.

L. Orci, P. Halban, A. Perrelet, M. Amherdt, M. Ravazzola, and G. W. Anderson . 1994. pH-independent and -dependent cleavage of proinsulin in the same secretory vesicle. J Cell Biol 126:1149–1156. Google Scholar

69.

A. A. Oliva Jr, D. F. Steiner, and S. J. Chan . 1995. Proprotein convertases in amphioxus: predicted structure and expression of proteases SPC2 and SPC3. Proc Natl Acad Sci USA 92:3591–3595. Google Scholar

70.

L. Paquet, F. Bergeron, A. Boudreault, N. G. Seidah, M. Chretien, M. Mbikay, and C. Lazure . 1994. The neuroendocrine precursor 7B2 is a sulfated protein proteolytically processed by a ubiquitous furin-like convertase. J Biol Chem 269:19279–19285. Google Scholar

71.

J. F. Powell, S. M. Reska-Skinner, M. O. Prakash, W. H. Fischer, M. Park, J. E. Rivier, A. G. Craig, G. O. Mackie, and A. M. Sherwood . 1996. Two new forms of gonadotropin-releasing hormone in a protochor-Proteolytic Processing by PC1 and PC2 1197 date and the evolutionary implications. Proc Natl Acad Sci USA 93:10461–10464. Google Scholar

72.

C. Robba, P. Rebuffat, G. Mazzocchi, and G. G. Nussdorfer . 1986. Long-term trophic action of alpha-melanocyte-stimulating hormone on the zona glomerulosa of the rat adrenal cortex. Acta Endocrinol (Copenh) 112:404–408. Google Scholar

73.

P. Rosa, P. Policastro, and E. Herbert . 1980. A cellular basis for the differences in regulation of synthesis and secretion of ACTH/endorphin peptides in anterior and intermediate lobes of the pituitary. J Exp Biol 89:215–237. Google Scholar

74.

W. W. Roth, R. B. Mackin, and B. D. Noe . 1993. Characterization and regulation of expression of the anglerfish prohormone processing endopeptidase PC1. Endocrine J 1:131–140. Google Scholar

75.

Y. Rouille, S. J. Duguay, K. Lund, M. Furuta, Q. Gong, G. Lipkind, A. A. Oliva Jr, S. J. Chan, and D. F. Steiner . 1995. Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front Neuroendocrinol 16:322–361. Google Scholar

76.

N. W. Rufaut, S. O. Brennan, D. Hakes, D. J. Dixon, and N. P. Birch . 1993. Purification and characterization of the candidate prohormone-processing enzyme SPC3 produced in a mouse L cell line. J Biol Chem 268:20291–20298. Google Scholar

77.

E. Schnabel, R. E. Mains, and M. G. Farquhar . 1989. Proteolytic processing of pro-ACTH/endorphin begins in the Golgi complex of pituitary corticotropes and AtT-20 cells. Mol Endocrinol 3:1223–1235. Google Scholar

78.

V. T. Schoonderwoert and G. J. Martens . 2001. Proton pumping in the secretory pathway. J Membrane Biol 182:159–169. Google Scholar

79.

N. Seidah and M. Chretien . 1992. Proprotein and prohormone convertases of the subtilisin family. Recent developments and future perspectives. Trends Endocrinol Metab 3:133–140. Google Scholar

80.

N. G. Seidah, L. Gaspar, P. Mion, M. Marcinkiewicz, M. Mbikay, and M. Chretien . 1990. cDNA sequence of two distinct pituitary proteins homologous to Kex2 and furin gene products: tissue-specific mRNAs encoding candidates for pro-hormone processing proteinases. DNA Cell Biol 9:415–424. Google Scholar

81.

N. G. Seidah, M. Marcinkiewicz, S. Benjannet, L. Gaspar, G. Beaubien, M. G. Mattei, C. Larure, M. Mbikay, and M. Chretien . 1991. Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, furin, and Kex2: distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2. Mol Endocrinol 5:111–122. Google Scholar

82.

N. G. Seidah, R. Day, J. Hamelin, A. Gaspar, M. W. Collard, and M. Chretien . 1992. Testicular expression of PC4 in the rat: molecular diversity of a novel germ cell-specific kex2/subtilisin-like proprotein convertase. Mol Endocrinol 6:1559–1570. Google Scholar

83.

N. G. Seidah, J. Hamelin, M. Mamarbachi, W. Dong, H. Tardos, M. Mbikay, M. Chretien, and R. Day . 1996. cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases. Proc Natl Acad Sci USA 93:3388–3393. Google Scholar

84.

N. G. Seidah and M. Chretien . 1999. Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 848:45–62. Google Scholar

85.

S. P. Smeekens and D. F. Steiner . 1990. Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2. J Biol Chem 265:2997–3000. Google Scholar

86.

A. B. Smit, S. Spijker, and W. P. Geraerts . 1992. Molluscan putative prohormone convertases: structural diversity in the central nervous system of Lymnaea stagnalis. FEBS Lett 312:213–218. Google Scholar

87.

D. G. Smyth, D. E. Massey, S. Zakarian, and M. D. A. Finnie . 1979. Endorphins are sored in biologically active and inactive forms: isolation of α-N-acetyl peptides. Nature 279:252–254. Google Scholar

88.

L. Song and L. D. Fricker . 1995. Purification and characterization of carboxypeptidase D a novel carboxypeptidase E-like enzyme, from bovine pituitary. J Biol Chem 270:25007–25013. Google Scholar

89.

D. F. Steiner 1991. The biosynthesis of biologically active peptides, a perspective. In “Peptide Biosynthesis and Processing”. Ed by L. D. Fricker CRC Press. Boca Raton. pp. 1–15. Google Scholar

90.

D. F. Swaab, M. Visser, and F. J. H. Tilders . 1976. Stimulation of intra-uterine growth in rat by α-MSH. J Endocrinol 70:445–452. Google Scholar

91.

S. Spijker, A. B. Smit, H. E. Sharp-Baker, R. Van Elk, E. R. Van Kesteren, J. Van Minnen, A. Kurosky, and W. P. M. Geraerts . 1999. Family of pro-hormone convertases in Lymnaea: characterization of two alternatively spliced furin-like transcripts and cell-specific regulation of their expression. J Neurobiol 41:399–413. Google Scholar

92.

S. Tanaka and K. Kurosumi . 1986. Differential subcellular localization of ACTH and α-MSH in corticotropes of the rat anterior pituitary. Cell Tissue Res 243:229–238. Google Scholar

93.

S. Tanaka, M. Nomizu, and K. Kurosumi . 1991. Intracellular sites of proteolytic processing of pro-opiomelanocortin in melanotrophs and corticotrophs in the rat pituitary. J Histochem Cytochem 39:809–821. Google Scholar

94.

S. Tanaka and K. Kurosumi . 1992. A certain step of proteolytic processing of proopiomelanocortin occurs during the transition between two distinct stages of secretory granules maturation in rat anterior pituitary corticotrophs. Endocrinology 131:779–786. Google Scholar

95.

S. Tanaka, S. Kurabuchi, H. Mochida, T. Kato, S. Takahashi, T. Watanabe, and K. Nakayama . 1996. Immunocytochemical localization of prohormone convertases PC1/PC3 and PC2 in rat pancreatic islets. Arch Histol Cyto 59:261–271. Google Scholar

96.

S. Tanaka, T. Yora, K. Nakayama, K. Inoue, and K. Kurosumi . 1997. Proteolytic processing of pro-opiomelanocortin occurs in acidifying secretory granules of AtT-20 cells. J Histochem Cytochem 45:425–436. Google Scholar

97.

K. Teter and H-P. H. Moore . 1998. Targeting and activation of peptide hormones in the secretory pathway. In “Proteolytic and Cellular Mechanisma in Prohormone and Protein Processing”. Ed by V. Y. H. Hook RG Landes Company. Austin. pp. 1–27. Google Scholar

98.

G. Thomas, B. A. Thorne, L. Thomas, R. G. Allen, D. E. Hruby, R. Fuller, and J. Thorner . 1988. Yeast KEX2 endopeptidase correctly cleaves a neuroendocrine prohormone in mammalian cells. Science 241:226–230. Google Scholar

99.

L. Thomas, R. Leduc, B. A. Thorne, S. P. Smeekens, D. F. Steiner, and G. Thomas . 1991. Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: evidence for a common core of neuroendocrine processing enzymes. Proc Natl Acad Sci USA 88:5297–5301. Google Scholar

100.

J. Tooze, S. A. Tooze, and S. D. Fuller . 1987. Sorting of progeny coronavirus from condensed secretory proteins at the exit from the trans-Golgi network of AtT20 cells. J Cell Biol 105:1215–1226. Google Scholar

101.

M. Uehara, Y. Yaoi, M. Suzuki, K. Takata, and S. Tanaka . 2001. Differential localization of prohormone convertase (PC1 and PC2) in two distinct types of secretory granules in rat pituitary gonadotrophs. Cell Tissue Res 304:43–49. Google Scholar

102.

D. Vieau, F. Gangnon, S. Jegou, J. M. Danger, and H. Vaudry . 1998. Characterization of the cDNA encoding the prohormone convertase PC2 and localization of the mRNA in the brain of the frog Rana ridibunda. Mol Brain Res 63:1–13. Google Scholar

103.

C. H. Westphal, L. Muller, A. Zhou, X. Zhu, S. Bonner-Weir, M. Schambelan, D. F. Steiner, I. Lindberg, and P. Leder . 1999. The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing's disease. Cell 96:689–700. Google Scholar

104.

W. C. Wetsel, Z. Liposits, N. G. Seidah, and S. Collins . 1995. Expression of candidate pro-GnRH processing enzymes in rat hypothalamus and an immortalized hypothalamic neuronal cell line. Neuroendocrinology 62:166–177. Google Scholar

105.

Y. Yaoi, M. Suzuki, H. Tomura, S. Kikuyama, and S. Tanaka . 2003. Molecular cloning and expression of prohormone convertases PC1 and PC2 in the pitutray gland of the bullfrog, Rana catesbeiana. Zool Sci 20:1139–1151. Google Scholar

106.

S. H. Yoo 1995. pH- and Ca2+-induced conformational change and aggregation of chromogranin B. Comparison with chromogra-1198 nin A and implication in secretory vesicle biogenesis. J Biol Chem 270:12578–12583. Google Scholar

107.

S. H. Yoo and M. S. Lewis . 1996. Effects of pH and Ca2+ on heterodimer and heterotetramer formation by chromogranin A and chromogranin B. J Biol Chem 271:17041–17046. Google Scholar

108.

A. Zhou, B. T. Bloomquist, and R. E. Mains . 1993. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavage in a strict temporal order during proopiomelanocortin biosynthetic processing. J Biol Chem 268:1763–1769. Google Scholar

109.

A. Zhou and R. E. Mains . 1994. Endoproteolytic processing of proopiomelanocortin and prohormone convertases 1 and 2 in neuroendocrine cells overexpressing prohormone convertases 1 or 2. J Biol Chem 269:17440–17447. Google Scholar

110.

A. Zhou, G. Webb, X. Zhu, and D. F. Steiner . 1999. Proteolytic processing in the secretory pathway. J Biol Chem 274:20745–20748. Google Scholar

111.

Y. Zhou and L. Lindberg . 1993. Purification and charcterization of the prohormone convertase PC1 (PC3). J Biol Chem 268:5615–5623. Google Scholar

112.

X. Zhu, Y. Rouille, N. S. Lamango, D. F. Steiner, and I. Lindberg . 1996. Internal cleavage of the inhibitory 7B2 carboxyl-terminal peptide by PC2: a potential mechanism for its inactivation. Proc Natl Sci USA 93:4919–4924. Google Scholar

113.

X. Zhu, A. Zhou, A. Dey, C. Norrbom, R. Carroll, C. Zhang, V. Laurent, I. Lindberg, R. Ugleholdt, J. J. Holst, and D. F. Steiner . 2002. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA 99:10293–10298. Google Scholar
Shigeyasu Tanaka "Comparative Aspects of Intracellular Proteolytic Processing of Peptide Hormone Precursors: Studies of Proopiomelanocortin Processing," Zoological Science 20(10), 1183-1198, (1 October 2003). https://doi.org/10.2108/zsj.20.1183
Accepted: 1 July 2003; Published: 1 October 2003
JOURNAL ARTICLE
16 PAGES


Share
SHARE
KEYWORDS
PC1
PC2
proopiomelanocortin
proteolytic processing
secretory granules
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top